TipRanks
Lakefront Biotherapeutics NV (DE:GXE)
XETRA:GXE
Germany Market
GXE
Lakefront Biotherapeutics NV
RESEARCH TOOLSreports

Lakefront Biotherapeutics NV (GXE) Cash flow

6 Followers

Lakefront Biotherapeutics NV Cash Flow

DE:GXE's free cash flow for Q1 2026 was €-78.74M. For the 2026 fiscal year, DE:GXE's free cash flow was decreased by €191.42M and operating cash flow was €-78.61M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
€ -197.01M€ -320.03M€ -405.97M€ -500.54M€ -503.83M
Investing Cash Flow
€ 228.37M€ 220.60M€ 71.19M€ -1.25B€ 541.24M
Financing Cash Flow
€ -3.27M€ -4.92M€ -5.00M€ -1.49M€ -3.88M
End Cash Position
€ 87.87M€ 64.24M€ 166.81M€ 508.12M€ 2.23B
Free Cash Flow
€ -210.71M€ -402.14M€ -425.24M€ -537.49M€ -561.71M
Currency in EUR

Lakefront Biotherapeutics NV Cash Flow